Morrison Briggs's Form 4 filing
Syndax Pharmaceuticals Inc (SNDX) · filed Sep 21, 2021
- Accession no.
- 0001562180-21-006038
- Filed
- Sep 21, 2021
- Trade date
- Sep 17-20, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.41M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morrison BriggsCIK 0001654430 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | Common Stock | MOption exerciseAcquired | +70,262 | $7.20 | +$505,886.4 | 118,598 | Direct | |
| Sep 17, 2021 | Common Stock | SSaleDisposed | −70,262 | $20.07F2 | −$1,410,158.34 | 48,336 | Direct | |
| Sep 20, 2021 | Common Stock | MOption exerciseAcquired | +50 | $7.20 | +$360 | 48,386 | Direct | |
| Sep 20, 2021 | Common Stock | SSaleDisposed | −50 | $20.00 | −$1,000 | 48,336 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | Common Stock | MOption exerciseDisposed | −70,262 | $0.00 | $0 | 0 | Direct | |
| Sep 20, 2021 | Common Stock | MOption exerciseDisposed | −50 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale prices ranged from $20.00 to $20.32.
Referenced by the price of 1 transaction in Table I.